Clinical trials in Papua New Guinea
43 studies list at least one site in Papua New Guinea. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the studies in Papua New Guinea recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Most studied here
Who runs them
Papua New Guinea Institute of Medical Research (7) · Lihir Medical Centre (7) · Menzies School of Health Research (4) · University Hospitals Cleveland Medical Center (3) · Curtin University (3) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (3) · Oriol Mitja (2) · Macfarlane Burnet Institute for Medical Research and Public Health Ltd (2)
What changed recently
From the registry's own updates since Oct 13, 2026.
Newly registered1
- Spatial Emanator Deployment Strategies for Malaria Control in Papua New GuineaNov 3, 2026NCT07912528
Studies
Recruiting first, then most recently updated. Showing 43 of 43 — search for more.
- Spatial Emanator Deployment Strategies for Malaria Control in Papua New GuineaNot yet recruitingNCT07912528Not applicable
- Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean ChildrenRecruitingNCT07052162Phase 4
- Postpartum 8-aminoquinoline Breast Milk StudyNot yet recruitingNCT07060404Phase 2/3
- Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.RecruitingNCT07468513Phase 4
- An Ultra-short Course of Primaquine for the Radical Cure of Vivax MalariaNot yet recruitingNCT07468526Phase 3
- Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated MalariaNot yet recruitingNCT07403643Phase 4
- A Revised Tafenoquine Dose to Improve Radical Cure for Vivax MalariaRecruitingNCT06148792Phase 3
- Repurposing Clinically Approved Drugs for Yaws With an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)CompletedNCT05764876Phase 3
- Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New GuineaCompletedNCT03462615
- Short Course Primaquine for the Radical Cure of P. Vivax - Papua New GuineaCompletedNCT05874271Not applicable
- Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG - Second TrialActive, not recruitingNCT07264686Phase 2
- Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in PregnancyActive, not recruitingNCT05426434Phase 3
- Emergency Department Triage in a Resource Constrained Setting: Application of the World Health Organization Triage Scale in Regional Papua New GuineaWithdrawnNCT04098705Not applicable
- Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNGCompletedNCT06690814Phase 2
- East New Britain Province Monitoring & EvaluationCompletedNCT04124250
- Systems Biology to Identify Biomarkers of Neonatal Vaccine ImmunogenicityCompletedNCT03246230Not applicable
- Estimating Usual Iodine Intake From Spot Urinary Iodine ConcentrationsCompletedNCT03602404
- Evaluation of an Intensive 3-round MDA Strategy Towards Yaws EradicationCompletedNCT03490123Phase 4
- Prevalence Studies After Triple Drug Therapy for Lymphatic FilariasisCompletedNCT03352206
- Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic FilariasisCompletedNCT02899936Not applicable
- An Accessible Low-cost Plant Treatment for Cutaneous UlcersCompletedNCT04453124Phase 2
- PCV13 in Non-pregnant Papua New Guinean WomenCompletedNCT04183322
- Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNGCompletedNCT03268252
- Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )CompletedNCT03676140Phase 3
- PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )CompletedNCT03664063Phase 2
- Papua New Guinean Duffy Negativity And Vivax MalarTerminatedNCT00138489
- Comparison of Two Different Doses of Azithromycin for Treatment of YawsCompletedNCT02344628Phase 3
- Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of AfricaCompletedNCT01975441Phase 2
- Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New GuineaCompletedNCT01955252Phase 3
- Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment CampaignsCompletedNCT02605720Phase 3
- Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial SplenomegalyWithdrawnNCT01785979Phase 3
- A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG WomenStatus unknownNCT02575755Phase 4
- Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax InfectionStatus unknownNCT02364583Phase 4
- Dual Point-of-care Test for the Diagnosis of YawsCompletedNCT01841203
- Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and MorbidityCompletedNCT02143934Phase 4
- Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean ChildrenStatus unknownNCT01619462Phase 3
- Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New GuineaCompletedNCT01136850Phase 3
- Pneumococcal Conjugate Vaccine FollowupCompletedNCT01414504Phase 2
- Artemether-Lumefantrine Clinical Effectiveness StudyCompletedNCT01599000Phase 4
- Single-dose Azithromycin for the Treatment of YawsCompletedNCT01382004Phase 3
- Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG InfantsCompletedNCT00285662Not applicable
- Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New GuineaCompletedNCT00219401Phase 2
- Cotrifazid Safety and Efficacy Against MalariaTerminatedNCT00322907Phase 2